Preparing for Comparative Effectiveness Research

Ernst & Young Pulse of the industry: Medtech report 2010
October 19, 2010

Most Americans first became aware of comparative effectiveness research (CER) when the infamous “death panel” debate broke out in early 2009, soon after Congress had allocated US$1.1 billion in economic stimulus funding to begin a major expansion of federally supported CER. Critics contended at the time that CER findings would lead to government-led health care rationing.

Representatives of the US medical device industry and other health care industries had already been engaged in serious discussions with Congress over CER for many months.

Link to Full Article: http://www.ey.com/Publication/vwLUAssets/Pulse_Industry_Medical_Technology_…